MedPath

Cervical Rippening With Antiprogesterone in Midtrimester Abortions

Phase 4
Completed
Conditions
Abortion, Missed
Interventions
Registration Number
NCT00410345
Lead Sponsor
Hadassah Medical Organization
Brief Summary

Induction of midtrimester abortion includes cervical ripening and then contraction to induce uterine evacuation. There are several protocols, but most of them include using prostaglandins (PG). The disadvantages of using PG include uncomfortable side effects and limits of using it for women after cesarean section. Mifepristone is an antiprogesterone drug and been used for induction of abortion in first and second trimesters abortions. The aim of this study is to explore the effectiveness of Mifepristone for cervical ripening before high dose Oxytocin drip.

Detailed Description

The aim of this study is to explore the effectiveness of Mifepristone for cervical ripening before high dose Oxytocin drip in midtrimester abortions. After informed consent, all the women will be randomized for Mifepristone or placebo. 48 hours later, high dose oxytocin drip will be started and we will examine the success rate to induce abortion, the duration from starting oxytocin till evacuation of uterus and side effects.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
145
Inclusion Criteria
  • midtrimester late abortion
  • midtrimester induced abortion
Exclusion Criteria
  • placenta previa
  • infected abortion
  • rupture of membranes
  • s/p cesarean section *2 or more

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
PitocinMifepristoneTreatment with Pitocin after mifegine
CytotecMifepristoneTreatment with cytotec after mifegine
Primary Outcome Measures
NameTimeMethod
success of abortion induction
abortion induction duration
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Hadassah Medical Organization

🇮🇱

Jerusalem, Israel

© Copyright 2025. All Rights Reserved by MedPath